GDF15 and metabolic dysfunction-associated steatotic liver disease: During metabolic liver disease progression, particularly at the critical transition stage from metabolic dysfunction-associated fatty liver disease (MASLD) to MASH, hepatic stress signaling activates transcription factors TFEB and DDIT3 to cooperatively regulate Gdf15 transcription [35].